Used primarily as a key intermediate in pharmaceutical synthesis, this compound enables the formation of complex heterocyclic structures through Suzuki-Miyaura cross-coupling reactions. Its boron-containing group facilitates carbon-carbon bond formation under mild conditions, making it valuable in the development of bioactive molecules and drug candidates. It is especially useful in constructing benzoxazine-based scaffolds found in central nervous system agents and anti-inflammatory compounds. The reagent’s stability and reactivity profile allow for high selectivity and yield in late-stage functionalization of drug-like molecules.